# 2025-08267: Red Tape Slashed to Ramp Up U.S. Critical Medicine Factories

2025-08267, Regulatory Relief To Promote Domestic Production of Critical Medicines, is a Federal Register presidential document from Executive Office of the President published 2025-05-08, effective 2025-05-05 (as of 2026-11-04).

- Canonical: https://policyrisk.com/federal-register/2025-08267
- As of: 2026-11-04
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-08267
- Title: Regulatory Relief To Promote Domestic Production of Critical Medicines
- Type: Presidential Document
- Agencies: Executive Office of the President
- Citation: 90 FR 19615
- Published: 2025-05-08
- Effective: 2025-05-05
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-11-04

## In one line

Red Tape Slashed to Ramp Up U.S. Critical Medicine Factories

## Summary

This new order helps American medicine makers speed up building and upgrading factories by cutting red tape and easing inspections. It’s designed to boost the local production of important medicines, making sure we’re ready for health emergencies and less dependent on other countries. These changes start right away and aim to save time and money, helping Americans get critical medicines faster and safer.

## Effects PRIA read

- FDA streamlines manufacturing review: benefit, medium. Within 180 days of May 5, 2025, the FDA must review regulations and guidance that apply to developing domestic pharmaceutical manufacturing and take steps to eliminate duplicative or unnecessary requirements, make reviews more timely and predictable, and accelerate development of new or expanded fa…
- EPA updates permitting rules: benefit, medium. Within 180 days of May 5, 2025, the Environmental Protection Agency must update regulations and guidance that apply to inspection and approval of new and expanded pharmaceutical manufacturing capacity to eliminate duplicative or unnecessary requirements and improve timeliness and predictability of…
- Single point of contact for permits: benefit, low. The lead agency for NEPA reviews must designate a single point of contact to coordinate with permit applicants, and the Office of Management and Budget will coordinate with that lead to expedite permit review and approval for pharmaceutical manufacturing projects. This coordination is directed unde…
- Army Corps to reassess water permits: benefit, low. Within 180 days of May 5, 2025, the Secretary of the Army, through the Assistant Secretary of the Army for Civil Works, must review nationwide permits issued under section 404 of the Clean Water Act and section 10 of the Rivers and Harbors Appropriation Act to determine whether an activity-specific…
- More foreign facility inspections; fees: mixed, low. Within 90 days of May 5, 2025, the FDA must develop improvements to its risk-based inspection regime to ensure routine reviews of overseas manufacturing facilities that supply U.S. medicines; these reviews are to be funded by increased fees on foreign manufacturing facilities to the extent consiste…

## Related documents

- [2026-22385](https://policyrisk.com/federal-register/2026-22385): Adjusting Imports of Robotics, Industrial Machinery, and Their Parts and Components Into the United States, 2026-11-02
- [2026-22292](https://policyrisk.com/federal-register/2026-22292): Further Modifying the Scope of Products of Canada Subject to the Additional Duties Imposed To Offset Canadian Discrimination Against the Co…, 2026-10-30
- [2026-22051](https://policyrisk.com/federal-register/2026-22051): Decreasing Housing Costs for the American People, 2026-10-28
- [2026-22052](https://policyrisk.com/federal-register/2026-22052): Presidential Determination Pursuant to Section 303 of the Defense Production Act of 1950, as Amended, on Domestic Petroleum Production, Ref…, 2026-10-28
- [2026-22049](https://policyrisk.com/federal-register/2026-22049): Adjusting Imports of Wind Turbines and Their Parts and Components Into the United States, 2026-10-28
- [2026-22050](https://policyrisk.com/federal-register/2026-22050): National Seafood Month, 2026, 2026-10-28

## Sources
- [2025-08267 on federalregister.gov](https://www.federalregister.gov/documents/2025/05/08/2025-08267/regulatory-relief-to-promote-domestic-production-of-critical-medicines)
- [2025-08267 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-05-08/pdf/2025-08267.pdf)

## Related
- [Previous: 2025-08266, Improving the Safety and Security of Biological Research](https://policyrisk.com/federal-register/2025-08266)
- [Next: 2025-08310, Continuation of the National Emergency With Respect to the Actions of the Gover…](https://policyrisk.com/federal-register/2025-08310)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-08267 (as of 2026-11-04).